WVXU: UC researchers launch stroke recovery study
Nationwide VERIFY study aims to predict return of upper arm function using MRI, TMS
University of Cincinnati researchers are leading a new nationwide stroke recovery study, hoping to identify biomarkers to predict which patients will recover upper arm function.
The VERIFY study is led by Pooja Khatri, MD, professor of neurology and director of the vascular neurology division in the UC College of Medicine’s Department of Neurology and Rehabilitation Sciences; co-director of the UC Gardner Neuroscience Institute Stroke Center of Excellence and the NIH StrokeNet National Coordinating Center housed at UC and a UC Health physician, and Achala Vagal, MD, vice chair of research and professor of radiology in UC’s College of Medicine and a UC Health neuroradiologist.
The study will use transcranial stimulation (TMS) and MRI, with Vagal leading the procedures and analysis of MRI imaging. Being able to predict recovery can lead to more specific trials and more informed patient care, the researchers said.
“Scientifically, for future trials and future studies, this study will be very informative," Vagal told WVXU. "But also, at a patient level in the future, it will really help to find out which patient needs which kind of therapy and how much of it is really going to help them recover.”
Featured photo at top of Dr. Khatri, left, and Dr. Vagal. Photo/Ravenna Rutledge/University of Cincinnati.
Spectrum News: UC students to mine cryptocurrency
December 6, 2021
A donation to the University of Cincinnati will provide lessons for UC students and raise funds for the School of Creative and Performing Arts, a public arts school in downtown Cincinnati, Spectrum News reported.
New opportunities in legal education
December 3, 2021
Susan Stephan, College of Law's new director of the MLS Program, answers questions.
Atlanta Journal Constitution: Ointment kills...
December 3, 2021
The Atlanta Journal Constitution published a story on research at the University of Cincinnati College of Medicine possibly adding a weapon to hospitals’ bacteria fighting arsenal.Using the topical drug called AB569 — a combination of acidified nitrite and ethylenediaminetetraacetic acid — promotes killing of antibiotic-resistant bacteria while enhancing the healing of wounds in a variety of burn injuries, the study found. The study was published in the journal Infection and Immunity.